Ignite Creation Date:
2025-12-25 @ 5:01 AM
Ignite Modification Date:
2025-12-26 @ 4:02 AM
Study NCT ID:
NCT01399918
Status:
COMPLETED
Last Update Posted:
2022-02-01
First Post:
2011-07-20
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC)
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-07
Start Date Type:
None
Primary Completion Date:
2020-12-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-12-28
Completion Date Type:
ACTUAL
First Submit Date:
2011-07-20
First Submit QC Date:
None
Study First Post Date:
2011-07-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-01-03
Results First Submit QC Date:
None
Results First Post Date:
2022-02-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-03
Last Update Post Date:
2022-02-01
Last Update Post Date Type:
ACTUAL